Effectiveness of Modafinil in Improving Cognitive Performance of University Students
NCT ID: NCT01365897
Last Updated: 2011-06-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
128 participants
INTERVENTIONAL
2010-09-30
2011-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Modafinil, Caffeine and Methylphenidate in Healthy Volunteers
NCT02071615
The Effect of Modafinil on Affective and Cognitive Processing
NCT03426202
Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHD
NCT00214981
Central Nervous System Stimulants and Physical Function in Children With Cerebral Palsy
NCT05675098
Motivation and Methylphenidate
NCT03190681
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Control Group
Modafinil
Modafinil 200mg
Modafinil 200mg
Modafinil 200mg taken orally.
Modafinil
Modafinil 200mg
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Modafinil
Modafinil 200mg
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with physical diseases.
* Patients using any psychotropic substances.
* History of chronic diseases.
* Pregnant women.
18 Years
25 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad de Valparaiso
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Universidad de Valparaiso
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alejandro Fernández, Psychologist
Role: PRINCIPAL_INVESTIGATOR
Universidad de Valparaiso
Eva Madrid, PhD
Role: STUDY_DIRECTOR
Universidad de Valparaiso
Andrés Painel, BM BCh
Role: STUDY_DIRECTOR
Universidad de Valparaiso
Jonathan Norambuena, BM BCh
Role: STUDY_DIRECTOR
Universidad de Valparaiso
Franco Mascayano, Psychologist
Role: STUDY_DIRECTOR
Universidad de Valparaiso
Walter Lips, Psychiatrist
Role: STUDY_DIRECTOR
Universidad de Valparaiso
Ortega Alonso, Psychologist
Role: STUDY_DIRECTOR
Universidad de Valparaiso
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Escuela de Medicina, Universidad de Valparaiso
Valparaíso, Región de Valparaíso, Chile
Escuela de Psicología, Universidad de Valparaiso
Valparaíso, Región de Valparaíso, Chile
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
04/2010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.